Search by Prescriber
Search by Drug
Also known as: Jardiance, Glyxambi, Synjardy, Trijardy
Find doctors, physicians, and healthcare providers who prescribe Empagliflozin in Pennsylvania. This page lists the top prescribers of Empagliflozin based on Medicare Part D data, including the number of claims, patients served, and total drug costs.
SYNJARDY SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an additional treatment to diet and exercise to improve glycemic control in adults and children aged 10 years and older with type 2 diabetes. It belongs to a class of drugs known as sodium-glucose cotransporter 2 inhibitor.
| Prescriber↕ | Location↕ | Type↕ | Claims↓ | Beneficiaries↕ | Cost↕ |
|---|---|---|---|---|---|
| Robert Pearlstein | Plymouth Meeting, PA | Internal Medicine | 1,519 | 155 | $413,591 |
| Manavendra Bakhshi | Philadelphia, PA | Cardiology | 1,347 | 257 | $1,118,596 |
| Stephan Kowalyk | Greensburg, PA | Endocrinology | 1,045 | 187 | $900,028 |
| George Jabbour | Altoona, PA | Cardiology | 954 | 205 | $789,220 |
| Donna Steel | Wynnewood, PA | Nurse Practitioner | 778 | 195 | $1,014,632 |
| Somera Ali | Limerick, PA | Endocrinology | 763 | 146 | $770,347 |